Waud Capital Partners, L.L.C. (“WCP”) today announced that its portfolio company, CarePoint Partners, L.L.C. (“CarePoint”), has acquired Family Focus Infusion, Inc. (“Family Focus”). Family Focus is a leading independent specialty pharmacy company offering home infusion therapy services in the five-county area of Jacksonville, Florida. The company provides various in-home infusion therapies including antibiotic, enteral, and intravenous immunoglobin. Family Focus is accredited by the Community Health Accreditation Program (“CHAP”).
“I look forward to the opportunity to work with the talented team at Family Focus to continue to grow in the marketplace. I anticipate they will be a large contributor to the long term success of CarePoint Partners,” said Dana Soper, CarePoint’s CEO. Matt Clary, Partner at Waud Capital Partners, added, “Family Focus has built a highly successful business in an extremely attractive market in Florida. We are excited to build upon this foundation and continue to expand the Company.” Arun Tahiliani, Founder and President of Family Focus, commented, “CarePoint Partners and Family Focus share the same philosophy and vision of providing the highest level of patient care. This partnership will allow us not only to maintain our current level of customer service and market strength, but also to expand into previously untapped markets.”

About CarePoint Partners, LLC
Dana Soper, CarePoint’s CEO, teamed with Waud Capital Partners to form CarePoint Partners, LLC (“CarePoint”) to acquire or develop and operate a network of infusion and specialty pharmacies in North America. Infusion pharmacy therapy involves the administration of medications and nutrients using intravenous (into the bloodstream), subcutaneous (under the skin) and epidural methods (into the membranes surrounding the spinal cord). Unlike pill-form medications, infused medicines require patient-specific mixing, special preparation, supervised administration and patient monitoring. Home therapy allows patients to receive IV medications without the inconvenience or cost of a hospital visit. Diagnoses that commonly require infusion therapy include infections that are unresponsive to oral antibiotics, cancer and cancer-related pain, gastrointestinal diseases or disorders, congestive heart failure, immune disorders, nutrition related problems, multiple sclerosis, hemophilia and growth hormone deficiencies. Specialty pharmacy services require less direct clinical interaction than home infusion, but still require patient monitoring, patient education and training for the administration of specialized pharmaceuticals, biopharmaceuticals and related services.

About Waud Capital Partners, L.L.C.
Waud Capital Partners (WCP) is a private equity investment firm founded in 1993 with more than $450 million of capital under management. WCP partners with exceptional management teams to invest in middle market buyouts, recapitalizations, industry consolidations and growth equity investments. The firm seeks to invest $10 million to $50 million in private companies in the following four areas: business and consumer services, healthcare services, industrial/specialty distribution and value-added manufacturing businesses. Typically, the companies in which WCP invests have enterprise values between $30 million and $250 million. Since its founding, Waud Capital Partners has successfully made more than seventy investments in a wide range of industries, including adhesives, air and water treatment, alarm monitoring, automotive components, coatings, consumer products, hospitals, lighting, litigation services, medical distribution, petroleum distribution, pharmaceuticals, publishing, sealants, specialty hospitals and tax consulting. Waud Capital oversees portfolio companies with combined revenues exceeding $5 billion. The firm is backed by a number of institutions, including Cheyenne Capital Fund, Citigroup, Middlebury College, SunAmerica, The Broad Foundation, The St. Paul Travelers Companies and the University of Chicago Hospitals, among others, as well as a number of high net worth families and individuals.